Reacción #2146686

ord-4bc09b23fe4a40ff938a0b354a991ac2

Ecuación de reacción

O=C(CBr)c1ccc(O)cc1
2-bromo-4′-hydroxyacetophenone
COc1ccc(N)nc1
2-amino-5-methoxypyridine
COc1ccc2nc(-c3ccc(O)cc3)cn2c1
2-(4′-hydroxyphenyl)-6-methoxyimidazo[1,2-a]pyridine
Rendimiento 81.6%

Disolventes

Condiciones de reacción

Temperatura
90°CELSIUS
Condiciones detalladas
See reaction.notes.procedure_details.

Tratamiento posterior

  1. 1
    OtroAfter the completion of the reaction
  2. 2
    Temperaturathe reaction solution was cooled down to room temperature
  3. 3
    Otroprecipitates
  4. 4
    Filtraciónwere filtered
  5. 5
    Otrorecovered
  6. 6
    LavadoThe precipitates were washed with acetonitrile
  7. 7
    Otrodried under reduced pressure
  8. 8
    workup.ADDITIONThen, about 20 mL of a saturated sodium hydrogencarbonate solution was added
  9. 9
    Otrothe mixture was sonicated for 5 minutes
  10. 10
    OtroPrecipitates
  11. 11
    Filtraciónwere filtered
  12. 12
    Otrorecovered from the resulting mixture
  13. 13
    Lavadosufficiently washed with water
  14. 14
    Otrodried under reduced pressure

Procedimiento

2.15 g (corresponding to 10.0 mmol) of 2-bromo-4′-hydroxyacetophenone and 1.25 g (corresponding to 10.0 mmol) of 2-amino-5-methoxypyridine were dissolved in 50 mL, of acetonitrile. The resulting solution was refluxed in an oil bath at 90° C. for 3.5 hours. After the completion of the reaction, the reaction solution was cooled down to room temperature, and precipitates were filtered and recovered. The precipitates were washed with acetonitrile and dried under reduced pressure. The resulting crude crystals were suspended in a mixed solution of 40 mL of water and 40 mL of methanol. Then, about 20 mL of a saturated sodium hydrogencarbonate solution was added thereto, and the mixture was sonicated for 5 minutes using a ultrasonic washing machine. Precipitates were filtered and recovered from the resulting mixture, sufficiently washed with water, and dried under reduced pressure, to obtain 1.96 g (corresponding to 8.16 mmol) of 2-(4′-hydroxyphenyl)-6-methoxyimidazo[1,2-a]pyridine (FIG. 2, Step 5).

Fuente

DOI: 10.6084/m9.figshare.5104873.v1Patente: US08277777B2uspto-grants-2012_10